Pefabloc® FG


Formulation : H-Gly-Pro-Arg-Pro-OH, AcOH

MW (g/mol): 485.5
Pepbloc FG binds to fibrinogen to inhibit the polymerization of the fibrin network, disrupting the mechanical properties of the clot.
Inhibits fibrino-formation and turbidity of fibrin network (e.g. TGT)

Reference 8-099-11 
Presentation Vial 
Packaging 3 x 50 mg 
Reference 8-099-01 
Presentation Vial 
Packaging 1 g 
Price list, safety data sheets and notices are accessible to our registered customers.